• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏病治疗的新时代:NLRP3炎性小体和细胞因子靶向疗法。

A new era in the treatment of kidney diseases: NLRP3 inflammasome and cytokine-targeted therapies.

作者信息

Leventoğlu Emre, Bakkaloğlu Sevcan A

机构信息

Department of Pediatric Nephrology, Konya City Hospital, Konya, Turkey.

Faculty of Medicine, Department of Pediatric Nephrology, Gazi University, Ankara, Turkey.

出版信息

Pediatr Nephrol. 2025 May;40(5):1515-1521. doi: 10.1007/s00467-024-06578-0. Epub 2024 Nov 1.

DOI:10.1007/s00467-024-06578-0
PMID:39485496
Abstract

The kidneys are crucial for filtering blood, managing overall body water, electrolyte, and acid-base balance, and regulating blood pressure. They remove metabolic waste products, toxins, and drugs. In addition, they limit inflammation by clearing cytokines and reduce immune cell activation by removing bacterial components. Dendritic cells (DCs) in the kidney maintain peripheral tolerance. About 85% of filtered water is reabsorbed by the proximal tubule, exposing distal nephron cells to high concentrations of low molecular weight antigens. These antigens are captured by DCs, helping to inactivate potentially autoreactive T cells and maintain tolerance to circulating antigens. In kidney failure, immune function is severely compromised due to the retention of toxins and cytokines, which activate immune cells and increase systemic inflammation. The kidneys are also vulnerable to immune-mediated diseases. Loss of immune homeostasis, characterized by over- or under-activity of the immune response, can adversely affect kidney function. With advances in immunology and cellular biology, biologic therapies targeting various pathways involved in the pathophysiology of kidney diseases are being developed. In this review, the immunologic aspects of kidney diseases and focus on cytokine-based therapies that may hold promise for the treatment of kidney diseases in the future will be presented.

摘要

肾脏对于过滤血液、维持全身水、电解质及酸碱平衡以及调节血压至关重要。它们能清除代谢废物、毒素和药物。此外,肾脏通过清除细胞因子来限制炎症,并通过去除细菌成分来减少免疫细胞的激活。肾脏中的树突状细胞(DCs)维持外周耐受。约85%被滤过的水在近端小管被重吸收,使远端肾单位细胞暴露于高浓度的低分子量抗原中。这些抗原被DCs捕获,有助于使潜在的自身反应性T细胞失活,并维持对循环抗原的耐受。在肾衰竭时,由于毒素和细胞因子的潴留,免疫功能会严重受损,这些毒素和细胞因子会激活免疫细胞并增加全身炎症。肾脏也易患免疫介导的疾病。免疫稳态的丧失,表现为免疫反应过度或不足,会对肾功能产生不利影响。随着免疫学和细胞生物学的进展,针对肾脏疾病病理生理学中各种相关途径的生物疗法正在研发中。在本综述中,将阐述肾脏疾病的免疫学方面,并重点介绍可能对未来肾脏疾病治疗具有前景的基于细胞因子的疗法。

相似文献

1
A new era in the treatment of kidney diseases: NLRP3 inflammasome and cytokine-targeted therapies.肾脏病治疗的新时代:NLRP3炎性小体和细胞因子靶向疗法。
Pediatr Nephrol. 2025 May;40(5):1515-1521. doi: 10.1007/s00467-024-06578-0. Epub 2024 Nov 1.
2
The emerging role of the inflammasome in kidney diseases.炎性小体在肾脏疾病中的新作用。
Curr Opin Nephrol Hypertens. 2014 May;23(3):204-10. doi: 10.1097/01.mnh.0000444814.49755.90.
3
The NLRP3 inflammasome in kidney disease and autoimmunity.肾病和自身免疫中的NLRP3炎性小体
Nephrology (Carlton). 2016 Sep;21(9):736-44. doi: 10.1111/nep.12785.
4
Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.含核苷酸结合结构域富含亮氨酸重复序列受体、含吡啉结构域的3炎性小体在肺部疾病中的调控与功能
Am J Respir Cell Mol Biol. 2016 Feb;54(2):151-60. doi: 10.1165/rcmb.2015-0231TR.
5
Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases.炎症小体组分 NLRP3 在慢性肾脏病发病机制中的多效性功能。
Kidney Int. 2019 Jul;96(1):58-66. doi: 10.1016/j.kint.2019.01.014. Epub 2019 Mar 4.
6
Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis.色素性肾病:炎症小体介导发病机制的新见解。
Int J Mol Sci. 2019 Apr 23;20(8):1997. doi: 10.3390/ijms20081997.
7
The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.嘌呤能 2X7 受体参与高脂肪饮食诱导的肾脏炎症和损伤:NLRP3 炎性体激活的可能作用。
J Pathol. 2013 Nov;231(3):342-53. doi: 10.1002/path.4237. Epub 2013 Sep 3.
8
The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms.NLRP3/ASC 炎性小体通过经典和非经典机制促进 T 细胞依赖性免疫复合物性肾小球肾炎。
Kidney Int. 2014 Nov;86(5):965-78. doi: 10.1038/ki.2014.161. Epub 2014 May 7.
9
A novel mechanism for regulating lung immune homeostasis: Zukamu granules alleviated acute lung injury in mice by inhibiting NLRP3 inflammasome activation and regulating Th17/Treg cytokine balance.一种调节肺部免疫稳态的新机制:祖卡木颗粒通过抑制NLRP3炎性小体激活和调节Th17/Treg细胞因子平衡减轻小鼠急性肺损伤。
J Ethnopharmacol. 2024 Apr 24;324:117831. doi: 10.1016/j.jep.2024.117831. Epub 2024 Jan 26.
10
LRRC8A is essential for hypotonicity-, but not for DAMP-induced NLRP3 inflammasome activation.LRRC8A 对于低渗诱导而非 DAMPs 诱导的 NLRP3 炎症小体激活是必需的。
Elife. 2020 Nov 20;9:e59704. doi: 10.7554/eLife.59704.

引用本文的文献

1
Association between complete blood count-derived inflammatory biomarkers and renal failure: a cross-sectional study from NHANES 2007-2020.全血细胞计数衍生的炎症生物标志物与肾衰竭之间的关联:一项来自2007 - 2020年美国国家健康与营养检查调查(NHANES)的横断面研究。
BMJ Open. 2025 Sep 1;15(9):e103381. doi: 10.1136/bmjopen-2025-103381.

本文引用的文献

1
Improving Kidney Disease Care: One Giant Leap for Nephrology.改善肾病护理:肾脏病学的一大飞跃。
Biomedicines. 2024 Apr 9;12(4):828. doi: 10.3390/biomedicines12040828.
2
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE).Ziltivekimab 对 CKD 3-5 期患者血红蛋白相关因素的影响:一项随机试验(RESCUE)分析。
J Am Soc Nephrol. 2024 Jan 1;35(1):74-84. doi: 10.1681/ASN.0000000000000245. Epub 2023 Dec 13.
3
Complement inhibitors in pediatric kidney diseases: new therapeutic opportunities.
儿童肾脏疾病中的补体抑制剂:新的治疗机遇
Pediatr Nephrol. 2024 May;39(5):1387-1404. doi: 10.1007/s00467-023-06120-8. Epub 2023 Sep 21.
4
IL-17C neutralization protects the kidney against acute injury and chronic injury.白细胞介素-17C 中和可保护肾脏免受急性损伤和慢性损伤。
EBioMedicine. 2023 Jun;92:104607. doi: 10.1016/j.ebiom.2023.104607. Epub 2023 May 30.
5
Changes and Significance of Interleukin 17 Expression in Patients After Renal Transplantation.肾移植患者白细胞介素17表达的变化及意义
Transplant Proc. 2023 Apr;55(3):562-568. doi: 10.1016/j.transproceed.2023.02.051. Epub 2023 Mar 30.
6
Autoinflammatory diseases and the kidney.自身炎症性疾病与肾脏。
Immunol Res. 2023 Aug;71(4):578-587. doi: 10.1007/s12026-023-09375-3. Epub 2023 Mar 29.
7
Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review.肾型AA淀粉样变性:临床表现、诊断及当前治疗选择:综述
Kidney Int. 2023 Mar;103(3):473-484. doi: 10.1016/j.kint.2022.10.028. Epub 2022 Dec 9.
8
Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome.利妥昔单抗在儿童特发性肾病综合征中的应用。
Clin J Am Soc Nephrol. 2023 Apr 1;18(4):533-548. doi: 10.2215/CJN.08570722. Epub 2023 Feb 22.
9
Interleukin-17A: Potential mediator and therapeutic target in hypertension.白细胞介素-17A:高血压的潜在介质和治疗靶点。
Nefrologia (Engl Ed). 2021 May-Jun;41(3):244-257. doi: 10.1016/j.nefroe.2021.06.003. Epub 2021 Jul 14.
10
Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis.阻断白细胞介素-6 可能成为淀粉样变性 AA 治疗的靶点。
Nefrologia (Engl Ed). 2022 Jan-Feb;42(1):28-32. doi: 10.1016/j.nefroe.2022.02.003. Epub 2022 Feb 16.